Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PULSE BIOSCIENCES, INC.PLSE · Entity 1151 | Director · Chairman of the Board | May 16, 2017 | May 18, 2017 |
| Paradium.AI, Inc.MVEN · Entity 7275 | Director | June 28, 2017 | June 30, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PULSE BIOSCIENCES, INC.
Report date May 16, 2017 · Filed May 18, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $27.14 · Expires 2027-05-16 | Direct | 15,000 |
Reported balance
After 2017-05-16 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2017-05-16 · Grant · Acquired 15,000 · Balance 15,000 F1: The shares subject to the option will vest in equal monthly installments over a one year period that will begin on June 1, 2017, subject to the Reporting Person's continued service through each vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares subject to the option will vest in equal monthly installments over a one year period that will begin on June 1, 2017, subject to the Reporting Person's continued service through each vesting date.
Paradium.AI, Inc.
Report date June 28, 2017 · Filed June 30, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| OptionSEC Table II · derivative / convertible security · Conversion / exercise price $1.61 · Expires 2027-06-28 | Direct | 70,000 |
Reported balance
After 2017-06-28 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2017-06-28 · Grant · Acquired 45,000 · Balance 70,000 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 28, 2017 Filed Jun 30, 2017 20:12 UTC | Paradium.AI, Inc. MVEN · Entity 7275 | GrantOption · Derivative | 45,000 | $0.00 Strike: $1.61 | $0.00 |
DisclosureSEC source: 0001144204-17-035229 · v470201_4.xml · derivative · entry 1 LEVANDE ROBERT · CIK 0001240092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 45,000 shares Expires 2027-06-28 Read SEC document |
| May 16, 2017 Filed May 18, 2017 20:40 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | GrantStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $27.14 | $0.00 |
DisclosureSEC source: 0001209191-17-033763 · doc4.xml · derivative · entry 1 LEVANDE ROBERT · CIK 0001240092 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2027-05-16 F1 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over a one year period that will begin on June 1, 2017, subject to the Reporting Person's continued service through each vesting date. Read SEC document |
| April 04, 2017 Filed Jun 9, 2017 19:36 UTC | Paradium.AI, Inc. MVEN · Entity 7275 | PurchaseCommon Stock | 26,730 | $1.24 | $33,145.20 |
DisclosureSEC source: 0001144204-17-031940 · v468376_4.xml · nonDerivative · entry 1 LEVANDE ROBERT · CIK 0001240092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 991,427 Read SEC document |
| January 18, 2017 Filed Jun 9, 2017 19:38 UTC | Paradium.AI, Inc. MVEN · Entity 7275 | GrantCommon Stock | 2,977 | $1.11 | $3,304.47 |
DisclosureSEC source: 0001144204-17-031944 · v468377_4.xml · nonDerivative · entry 1 LEVANDE ROBERT · CIK 0001240092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 964,697 Read SEC document |
| November 16, 2016 Filed Nov 16, 2016 18:12 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | GrantWarrant (right to buy) · Derivative | 85,385 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001209191-16-150672 · doc4.xml · derivative · entry 1 LEVANDE ROBERT · CIK 0001240092 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,385 Underlying: Common Stock · 85,385 shares Expires 2021-05-13 F1 · security: The warrant was originally issued to MDB Capital Group, LLC ("MDB"), pursuant to that certain Underwriting Agreement, dated May 17, 2016, between the Company and MDB as representative of the underwriters in connection with the Issuer's initial public offering, and subsequently re-issued to the Reporting Person. Read SEC document |
| November 04, 2016 Filed Nov 8, 2016 19:41 UTC | Paradium.AI, Inc. IMMS · Entity 7275 | GrantWarrant · Derivative | 292,402 | $0.00 Strike: $0.20 | $0.00 |
DisclosureSEC source: 0001144204-16-132375 · v452544_4.xml · derivative · entry 5 LEVANDE ROBERT · CIK 0001240092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 292,402 Underlying: Common Stock · 292,402 shares Expires 2021-11-04 Read SEC document |
| October 04, 2016 Filed Nov 8, 2016 19:41 UTC | Paradium.AI, Inc. IMMS · Entity 7275 | GrantCommon Stock | 15,625 | $0.20 | $3,125.00 |
DisclosureSEC source: 0001144204-16-132375 · v452544_4.xml · nonDerivative · entry 4 LEVANDE ROBERT · CIK 0001240092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 961,720 Read SEC document |
| July 11, 2016 Filed Nov 8, 2016 19:41 UTC | Paradium.AI, Inc. IMMS · Entity 7275 | GrantCommon Stock | 19,531 | $0.16 | $3,124.96 |
DisclosureSEC source: 0001144204-16-132375 · v452544_4.xml · nonDerivative · entry 3 LEVANDE ROBERT · CIK 0001240092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 946,095 Read SEC document |
| April 12, 2016 Filed Nov 8, 2016 19:41 UTC | Paradium.AI, Inc. IMMS · Entity 7275 | GrantCommon Stock | 19,531 | $0.16 | $3,124.96 |
DisclosureSEC source: 0001144204-16-132375 · v452544_4.xml · nonDerivative · entry 2 LEVANDE ROBERT · CIK 0001240092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 926,564 Read SEC document |
| January 11, 2016 Filed Nov 8, 2016 19:41 UTC | Paradium.AI, Inc. IMMS · Entity 7275 | GrantCommon Stock | 41,667 | $0.15 | $6,250.05 |
DisclosureSEC source: 0001144204-16-132375 · v452544_4.xml · nonDerivative · entry 1 LEVANDE ROBERT · CIK 0001240092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 907,033 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.